Activin/Nodal Signaling and Pluripotency

Vitamins and Hormones

Volumn 85, Issue , 2011, Pages 39-58

  Chng, Zhenzhi ^a   Vallier, Ludovic ^b   Pedersen, Roger ^b  

^a INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Activin; Embryonic stem cells; Endoderm; Gastrulation; Mesoderm; Neuroectoderm; Nodal; Pluripotency

Indexed keywords

ACTIVIN; NODAL SIGNALING PROTEIN; PROTEIN NODAL; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; BOOK; CELL DIFFERENTIATION; CYTOLOGY; EMBRYONIC STEM CELL; HUMAN; METABOLISM; PHYSIOLOGY; PLURIPOTENT STEM CELL; SIGNAL TRANSDUCTION;

ACTIVINS; ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; NODAL PROTEIN; NODAL SIGNALING LIGANDS; PLURIPOTENT STEM CELLS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 79951864875     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385961-7.00003-2     Document Type: Book

References (104)

1. Alberio R., Croxall N., Allegrucci C. Pig epiblast stem cells depend on activin/nodal signaling for pluripotency and self renewal. Stem Cells Dev. 2010, 19(10):1627-1636.
2. Amit M., Carpenter M.K., Inokuma M.S., Chiu C.P., Harris C.P., Waknitz M.A., Itskovitz-Eldor J., Thomson J.A. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 2000, 227:271-278.
3. Amit M., Shariki C., Margulets V., Itskovitz-Eldor J. Feeder layer- and serum-free culture of human embryonic stem cells. Biol. Reprod. 2004, 70:837-845.
4. Attisano L., Lee-Hoeflich S.T. The Smads. Genome Biol. 2001, 2(8). reviews 3010.1-3010.8.
5. Attisano L., Wrana J.L. Signal transduction by the TGF-beta superfamily. Science 2002, 296:1646-1647.
6. Beattie G.M., Lopez A.D., Bucay N., Hinton A., Firpo M.T., King C.C., Hayek A. Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells 2005, 23:489-495.
7. Beddington R.S., Robertson E.J. An assessment of the developmental potential of embryonic stem cells in the midgestation mouse embryo. Development 1989, 105:733-737.
8. Besser D. Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. J. Biol. Chem. 2004, 279:45076-45084.
9. Boeuf H., Hauss C., Graeve F.D., Baran N., Kedinger C. Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells. J. Cell Biol. 1997, 138:1207-1217.
10. Brandenberger R., Khrebtukova I., Thies R.S., Miura T., Jingli C., Puri R., Vasicek T., Lebkowski J., Rao M. MPSS profiling of human embryonic stem cells. BMC Dev. Biol. 2004, 4:10.
11. Brandenberger R., Wei H., Zhang S., Lei S., Murage J., Fisk G.J., Li Y., Xu C., Fang R., Guegler K., et al. Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. Nat. Biotechnol. 2004, 22:707-716.
12. Brennan J., Lu C.C., Norris D.P., Rodriguez T.A., Beddington R.S., Robertson E.J. Nodal signalling in the epiblast patterns the early mouse embryo. Nature 2001, 411:965-969.
13. Brons I.G., Smithers L.E., Trotter M.W., Rugg-Gunn P., Sun B., Chuva de Sousa Lopes S.M., Howlett S.K., Clarkson A., Ahrlund-Richter L., Pedersen R.A., et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007, 448:191-195.
14. Calhoun J.D., Rao R.R., Warrenfeltz S., Rekaya R., Dalton S., McDonald J., Stice S.L. Transcriptional profiling of initial differentiation events in human embryonic stem cells. Biochem. Biophys. Res. Commun. 2004, 323:453-464.
15. Camus A., Perea-Gomez A., Moreau A., Collignon J. Absence of Nodal signaling promotes precocious neural differentiation in the mouse embryo. Dev. Biol. 2006, 295:743-755.
16. Casellas R., Brivanlou A.H. Xenopus Smad7 inhibits both the activin and BMP pathways and acts as a neural inducer. Dev. Biol. 1998, 198:1-12.
17. Chen C., Ware S.M., Sato A., Houston-Hawkins D.E., Habas R., Matzuk M.M., Shen M.M., Brown C.W. The Vg1-related protein Gdf3 acts in a Nodal signaling pathway in the pre-gastrulation mouse embryo. Development 2006, 133:319-329.
18. Chng Z., Teo A., Pedersen R.A., Vallier L. SIP1 mediates cell-fate decisions between neuroectoderm and mesendoderm in human pluripotent stem cells. Cell Stem Cell 2010, 6:59-70.
19. Conlon F.L., Barth K.S., Robertson E.J. A novel retrovirally induced embryonic lethal mutation in the mouse: Assessment of the developmental fate of embryonic stem cells homozygous for the 413.d proviral integration. Development 1991, 111:969-981.
20. Conlon F.L., Lyons K.M., Takaesu N., Barth K.S., Kispert A., Herrmann B., Robertson E.J. A primary requirement for nodal in the formation and maintenance of the primitive streak in the mouse. Development 1994, 120:1919-1928.
21. Daheron L., Opitz S.L., Zaehres H., Lensch M.W., Andrews P.W., Itskovitz-Eldor J., Daley G.Q. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells 2004, 22:770-778.
22. D'Amour K.A., Agulnick A.D., Eliazer S., Kelly O.G., Kroon E., Baetge E.E. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 2005, 23:1534-1541.
23. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
24. Gardner R.L. Mouse chimeras obtained by the injection of cells into the blastocyst. Nature 1968, 220:596-597.
25. Gardner R.L., Cockroft D.L. Complete dissipation of coherent clonal growth occurs before gastrulation in mouse epiblast. Development 1998, 125:2397-2402.
26. Gearing D.P., Gough N.M., King J.A., Hilton D.J., Nicola N.A., Simpson R.J., Nice E.C., Kelso A., Metcalf D. Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J. 1987, 6:3995-4002.
27. Gilbert S.F. Developmental Biology 2003, Sinauer Associates, Sunderland, MA, USA. seventh ed.
28. Greber B., Lehrach H., Adjaye J. Fibroblast growth factor 2 modulates transforming growth factor beta signaling in mouse embryonic fibroblasts and human ESCs (hESCs) to support hESC self-renewal. Stem Cells 2007, 25:455-464.
29. Gurdon J.B., Melton D.A. Nuclear reprogramming in cells. Science 2008, 322:1811-1815.
30. Hayashi Y., Furue M.K., Tanaka S., Hirose M., Wakisaka N., Danno H., Ohnuma K., Oeda S., Aihara Y., Shiota K., et al. BMP4 induction of trophoblast from mouse embryonic stem cells in defined culture conditions on laminin. In Vitro Cell. Dev. Biol. Anim. 2010, 46(5):416-430.
31. Heit J.J., Kim S.K. Embryonic stem cells and islet replacement in diabetes mellitus. Pediatr. Diab. 2004, 5(Suppl. 2):5-15.
32. Hondo E., Stewart C.L. Profiling gene expression in growth-arrested mouse embryos in diapause. Genome Biol. 2005, 6:202.
33. Humphrey R.K., Beattie G.M., Lopez A.D., Bucay N., King C.C., Firpo M.T., Rose-John S., Hayek A. Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Cells 2004, 22:522-530.
34. James D., Levine A.J., Besser D., Hemmati-Brivanlou A. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 2005, 132:1273-1282.
35. Janssens S. Human embryonic stem cells for cardiac repair: The focus is on refined selection and cardiopoietic programming. Heart 2007, 93:1173-1174.
36. Jones C.M., Kuehn M.R., Hogan B.L., Smith J.C., Wright C.V. Nodal-related signals induce axial mesoderm and dorsalize mesoderm during gastrulation. Development 1995, 121:3651-3662.
37. Kleinsmith L.J., Pierce G.B. Multipotentiality of single embryonal carcinoma cells. Cancer Res. 1964, 24:1544-1551.
38. Kretzschmar M., Massague J. SMADs: Mediators and regulators of TGF-beta signaling. Curr. Opin. Genet. Dev. 1998, 8:103-111.
39. Lawson K.A., Meneses J.J., Pedersen R.A. Clonal analysis of epiblast fate during germ layer formation in the mouse embryo. Development 1991, 113:891-911.
40. Lawson K.A., Dunn N.R., Roelen B.A., Zeinstra L.M., Davis A.M., Wright C.V., Korving J.P., Hogan B.L. Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev. 1999, 13:424-436.
41. Levenstein M.E., Ludwig T.E., Xu R.H., Llanas R.A., VanDenHeuvel-Kramer K., Manning D., Thomson J.A. Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Stem Cells 2006, 24:568-574.
42. Levine A.J., Brivanlou A.H. GDF3, a BMP inhibitor, regulates cell fate in stem cells and early embryos. Development 2006, 133:209-216.
43. Levine A.J., Levine Z.J., Brivanlou A.H. GDF3 is a BMP inhibitor that can activate Nodal signaling only at very high doses. Dev. Biol. 2009, 325:43-48.
44. Ling N., Ying S.Y., Ueno N., Shimasaki S., Esch F., Hotta M., Guillemin R. Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 1986, 321:779-782.
45. Lowry W.E., Richter L., Yachechko R., Pyle A.D., Tchieu J., Sridharan R., Clark A.T., Plath K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. USA 2008, 105:2883-2888.
46. Ludwig T.E., Bergendahl V., Levenstein M.E., Yu J., Probasco M.D., Thomson J.A. Feeder-independent culture of human embryonic stem cells. Nat. Methods 2006, 3:637-646.
47. Ludwig T.E., Levenstein M.E., Jones J.M., Berggren W.T., Mitchen E.R., Frane J.L., Crandall L.J., Daigh C.A., Conard K.R., Piekarczyk M.S., et al. Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 2006, 24:185-187.
48. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 1981, 78:7634-7638.
49. Matzuk M.M., Kumar T.R., Vassalli A., Bickenbach J.R., Roop D.R., Jaenisch R., Bradley A. Functional analysis of activins during mammalian development. Nature 1995, 374:354-356.
50. McLean A.B., D'Amour K.A., Jones K.L., Krishnamoorthy M., Kulik M.J., Reynolds D.M., Sheppard A.M., Liu H., Xu Y., Baetge E.E., et al. Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells 2007, 25:29-38.
51. Mesnard D., Guzman-Ayala M., Constam D.B. Nodal specifies embryonic visceral endoderm and sustains pluripotent cells in the epiblast before overt axial patterning. Development 2006, 133:2497-2505.
52. Mishina Y., Suzuki A., Ueno N., Behringer R.R. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev. 1995, 9:3027-3037.
53. Miura T., Luo Y., Khrebtukova I., Brandenberger R., Zhou D., Thies R.S., Vasicek T., Young H., Lebkowski J., Carpenter M.K., et al. Monitoring early differentiation events in human embryonic stem cells by massively parallel signature sequencing and expressed sequence tag scan. Stem Cells Dev. 2004, 13:694-715.
54. Miyazono K., Kusanagi K., Inoue H. Divergence and convergence of TGF-beta/BMP signaling. J. Cell. Physiol. 2001, 187:265-276.
55. Moustafa L.A., Brinster R.L. Induced chimaerism by transplanting embryonic cells into mouse blastocysts. J. Exp. Zool. 1972, 181:193-201.
56. Nakayama T., Gardner H., Berg L.K., Christian J.L. Smad6 functions as an intracellular antagonist of some TGF-beta family members during Xenopus embryogenesis. Genes Cells 1998, 3:387-394.
57. Newman M.B., Bakay R.A. Therapeutic potentials of human embryonic stem cells in Parkinson's disease. Neurotherapeutics 2008, 5:237-251.
58. Nichols J., Evans E.P., Smith A.G. Establishment of germ-line-competent embryonic stem (ES) cells using differentiation inhibiting activity. Development 1990, 110:1341-1348.
59. Nichols J., Chambers I., Taga T., Smith A. Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. Development 2001, 128:2333-2339.
60. Niwa H., Burdon T., Chambers I., Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 1998, 12:2048-2060.
61. Okita K., Hong H., Takahashi K., Yamanaka S. Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat. Protoc. 2010, 5:418-428.
62. Ou L., Wang X., Zou F. Is iPS cell the panacea?. IUBMB Life 2010, 62:170-175.
63. Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., Lensch M.W., Cowan C., Hochedlinger K., Daley G.Q. Disease-specific induced pluripotent stem cells. Cell 2008, 134:877-886.
64. Park I.H., Lerou P.H., Zhao R., Huo H., Daley G.Q. Generation of human-induced pluripotent stem cells. Nat. Protoc. 2008, 3:1180-1186.
65. Rebagliati M.R., Toyama R., Fricke C., Haffter P., Dawid I.B. Zebrafish nodal-related genes are implicated in axial patterning and establishing left-right asymmetry. Dev. Biol. 1998, 199:261-272.
66. Reynolds D., Vallier L., Chng Z., Pedersen R.A. Signalling pathways in embryonic stem cells. Regulatory Networks in Stem Cells 2009, Humana Press, New York, NY, pp. 293-308. V.K. Rajasekhar, M.C. Vemuri (Eds.).
67. Robertson E.J., Norris D.P., Brennan J., Bikoff E.K. Control of early anterior-posterior patterning in the mouse embryo by TGF-beta signalling. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2003, 358:1351-1357. discussion 1357.
68. Ronaghi M., Erceg S., Moreno-Manzano V., Stojkovic M. Challenges of stem cell therapy for spinal cord injury: Human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells?. Stem Cells 2010, 28:93-99.
69. Rosler E.S., Fisk G.J., Ares X., Irving J., Miura T., Rao M.S., Carpenter M.K. Long-term culture of human embryonic stem cells in feeder-free conditions. Dev. Dyn. 2004, 229:259-274.
70. Schier A.F. Nodal signaling in vertebrate development. Annu. Rev. Cell Dev. Biol. 2003, 19:589-621.
71. Smith A.G., Hooper M.L. Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev. Biol. 1987, 121:1-9.
72. Smith A.G., Heath J.K., Donaldson D.D., Wong G.G., Moreau J., Stahl M., Rogers D. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988, 336:688-690.
73. Smith J.C., Price B.M., Van Nimmen K., Huylebroeck D. Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin A. Nature 1990, 345:729-731.
74. Smith J.R., Vallier L., Lupo G., Alexander M., Harris W.A., Pedersen R.A. Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Dev. Biol. 2008, 313:107-117.
75. Solter D., Skreb N., Damjanov I. Extrauterine growth of mouse egg-cylinders results in malignant teratoma. Nature 1970, 227:503-504.
76. Stevens L.C. The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos. Dev. Biol. 1970, 21:364-382.
77. Stevens L.C., Little C.C. Spontaneous testicular teratomas in an inbred strain of mice. Proc. Natl. Acad. Sci. USA 1954, 40:1080-1087.
78. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
79. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
80. Tesar P.J., Chenoweth J.G., Brook F.A., Davies T.J., Evans E.P., Mack D.L., Gardner R.L., McKay R.D. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007, 448:196-199.
81. Thomson J.A., Marshall V.S. Primate embryonic stem cells. Curr. Top. Dev. Biol. 1998, 38:133-165.
82. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
83. Valdimarsdottir G., Mummery C. Functions of the TGFbeta superfamily in human embryonic stem cells. APMIS 2005, 113:773-789.
84. Vale W., Rivier J., Vaughan J., McClintock R., Corrigan A., Woo W., Karr D., Spiess J. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 1986, 321:776-779.
85. Vallier L., Pedersen R.A. Human embryonic stem cells: An in vitro model to study mechanisms controlling pluripotency in early mammalian development. Stem Cell Rev. 2005, 1:119-130.
86. Vallier L., Reynolds D., Pedersen R.A. Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev. Biol. 2004, 275:403-421.
87. Vallier L., Alexander M., Pedersen R.A. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 2005, 118:4495-4509.
88. Vallier L., Mendjan S., Brown S., Chng Z., Teo A., Smithers L.E., Trotter M.W., Cho C.H., Martinez A., Rugg-Gunn P., et al. Activin/Nodal signalling maintains pluripotency by controlling Nanog expression. Development 2009, 136:1339-1349.
89. Vallier L., Touboul T., Brown S., Cho C., Bilican B., Alexander M., Cedervall J., Chandran S., Ahrlund-Richter L., Weber A., et al. Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells. Stem Cells 2009, 27:2655-2666.
90. Vallier L., Touboul T., Chng Z., Brimpari M., Hannan N., Millan E., Smithers L.E., Trotter M., Rugg-Gunn P., Weber A., et al. Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways. PLoS ONE 2009, 4:e6082.
91. Varlet I., Collignon J., Robertson E.J. Nodal expression in the primitive endoderm is required for specification of the anterior axis during mouse gastrulation. Development 1997, 124:1033-1044.
92. Verlinsky Y., Strelchenko N., Kukharenko V., Rechitsky S., Verlinsky O., Galat V., Kuliev A. Human embryonic stem cell lines with genetic disorders. Reprod. Biomed. Online 2005, 10:105-110.
93. Williams R.L., Hilton D.J., Pease S., Willson T.A., Stewart C.L., Gearing D.P., Wagner E.F., Metcalf D., Nicola N.A., Gough N.M. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 1988, 336:684-687.
94. Winnier G., Blessing M., Labosky P.A., Hogan B.L. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 1995, 9:2105-2116.
95. Wrighton K.H., Lin X., Yu P.B., Feng X.H. Transforming growth factor beta can stimulate Smad1 phosphorylation independently of bone morphogenic protein receptors. J. Biol. Chem. 2009, 284:9755-9763.
96. Xia Y., Schneyer A.L. The biology of activin: Recent advances in structure, regulation and function. J. Endocrinol. 2009, 202:1-12.
97. Xiao L., Yuan X., Sharkis S.J. Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells 2006, 24:1476-1486.
98. Xu R.H. In vitro induction of trophoblast from human embryonic stem cells. Methods Mol. Med. 2006, 121:189-202.
99. Xu R.H., Sampsell-Barron T.L., Gu F., Root S., Peck R.M., Pan G., Yu J., Antosiewicz-Bourget J., Tian S., Stewart R., et al. NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 2008, 3:196-206.
100. Yamamoto M., Saijoh Y., Perea-Gomez A., Shawlot W., Behringer R.R., Ang S.L., Hamada H., Meno C. Nodal antagonists regulate formation of the anteroposterior axis of the mouse embryo. Nature 2004, 428:387-392.
101. Yao S., Chen S., Clark J., Hao E., Beattie G.M., Hayek A., Ding S. Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc. Natl. Acad. Sci. USA 2006, 103:6907-6912.
102. Ying Q.L., Nichols J., Chambers I., Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 2003, 115:281-292.
103. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
104. Zhou H., Wu S., Joo J.Y., Zhu S., Han D.W., Lin T., Trauger S., Bien G., Yao S., Zhu Y., et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009, 4:381-384.